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Abstract
Background: Sera from children with post-varicella infections have autoantibodies that react with
centrosomes in brain and tissue culture cells. We investigated the sera of children with infections
and post-varicella ataxia and related conditions for reactivity to five recombinant centrosome
proteins: γγ-enolase, pericentrin, ninein, PCM-1, and Mob1.
Methods: Sera from 12 patients with acute post-varicella ataxia, 1 with post-Epstein Barr virus
(EBV) ataxia, 5 with uncomplicated varicella infections, and other conditions were tested for
reactivity to cryopreserved cerebellum tissue and recombinant centrosome proteins. The
distribution of pericentrin in the cerebellum was studied by indirect immunofluorescence (IIF) using
rabbit antibodies to the recombinant protein. Antibodies to phospholipids (APL) were detected by
ELISA.
Results: Eleven of 12 children with post-varicella ataxia, 4/5 children with uncomplicated varicella
infections, 1/1 with post-EBV ataxia, 2/2 with ADEM, 1/2 with neuroblastoma and ataxia, and 2/2
with cerebellitis had antibodies directed against 1 or more recombinant centrosome antigens.
Antibodies to pericentrin were seen in 5/12 children with post-varicella ataxia but not in any of the
other sera tested. IIF demonstrated that pericentrin is located in axons and centrosomes of
cerebellar cells. APL were detected in 75% of the sera from children with post-varicella ataxia and
50% of children with varicella without ataxia and in none of the controls.
Conclusion: This is the first study to show the antigen specificity of anti-centrosome antibodies
in children with varicella. Our data suggest that children with post-varicella ataxia have unique
autoantibody reactivity to pericentrin.
Background
There are 3 million cases of chicken pox each year in the
United States and 90% of this infection occurs in children
1–14 years of age [1]. The sequelae of varicella infection
in children includes a number of severe complications
such as purpura fulminans and thromboembolism [2,3].
In these conditions, autoantibodies to a variety of phos-
pholipids and protein related to coagulation were
reported and the related syndrome was referred to as The
Varicella-Autoantibody Syndrome [3]. Encephalitis is
another of sequelae of varicella in children that accounts
for 20% of hospital admissions due to varicella [4]. A
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cerebellar syndrome associated with post-infectious and
post-vaccinial states that usually begins abruptly 5 to 6
days following the subsidence of a rash, is manifest prima-
rily as ataxia. This syndrome is common following vari-
cella but also appears in measles, rubella and Epstein Barr
virus (EBV) infections [1,5–7]. The course is usually mild
and most children recover, but it can progress in some
children to more severe disease as manifested by vomit-
ing, dehydration and drowsiness. Although central nerv-
ous system complications usually develop within a week
after eruption, they may be delayed for up to 21 days.
The pathogenesis of post-varicella cerebellar ataxia is
unknown. A number of autoantibodies have been
described in other post-viral conditions, including
antineuronal antibodies in a case of post-infectious cere-
bellar ataxia following EBV infection [6], antibodies to
Purkinje cells in children with opsoclonus myoclonus
associated with neuroblastoma or a prodromal viral ill-
ness [5], and antibodies to centrioles in 2 children with
ataxia and other central nervous system manifestations
following Mycoplasma pneumoniae infection [8]. In a recent
study of children with post-varicella ataxia, we found anti-
bodies to cerebral and cerebellar tissue [9].
A family of proteins located at the centrosome that react
with human autoantibodies include pericentrin, ninein,
enolase, PCM 1 and a newer autoantigen, Mob1 [10,11].
These components are part of the pericentriolar material
(PCM) that surrounds the centrioles and mediates func-
tions such as microtubule organization and recruitment
of proteins to the centrosome. Pericentrin in particular
has been shown to be an important structural protein
within the PCM [12] and exist as particles in the cytoskel-
eton. These particles transit to the centrosome via the
motor protein dynein [12].
Antibodies directed against centrosomes have been
described in a number of conditions including arthritis,
Raynaud's phenomenon and systemic sclerosis [11,13–
18]. In addition, 'naturally' occurring antibodies to cen-
trosomes have been described in laboratory rabbits [19].
The specific antigenic target of many of these autoanti-
bodies remains undefined but with the identification of
centrosome components and the availability of the
cDNAs and respective recombinant proteins, systematic
studies of autoantibody specificity can now be deter-
mined with more precision.
Most children with post-infectious ataxia have a mild
course but some are more severely affected. If the mecha-
nisms that lead to the development of post-infectious cer-
ebellar ataxia are more completely understood, then a
rational approach to treatment could be considered. We
investigated the possibility that autoantibodies to specific
centrosome proteins are associated with a subset of chil-
dren with post-varicella acute cerebellar ataxia.
Methods
Patients & Sera
Children with chicken pox and subsequent cerebellar
ataxia were included in this study [8,9,9]. Blood samples
were obtained at the first visit and, in all but 4 patients, at
a convalescent stage 2 weeks later. We also obtained acute
blood samples from 5 siblings of those with post-varicella
ataxia with chicken-pox but without ataxia, from 20 nor-
mal controls, 20 children with juvenile chronic arthritis, 1
child with post-EBV ataxia, 2 with acute disseminated
encephalomyelitis (ADEM), and 1 with neuroblastoma
and ataxia, and 1 with cerebellitis. Varicella serology to
confirm the clinical diagnosis included an ELISA for IgG
antibodies at onset and complement fixation titer at onset
and at 2 weeks. Other control sera were from ongoing
serological studies in the advanced Diagnostics Labora-
tory at the University of Calgary. All sera were stored at -
20°C.
Indirect immunofluorescence (IIF)
Conventional IF was performed on commercially availa-
ble HEp-2 cells (Immuno Concepts Inc., Sacramento, CA)
and formalin-fixed HeLa cells using a fluorescein-conju-
gated goat anti-human IgG (light and heavy chain) as pre-
viously described [20]. Reactivity of patients' sera was also
tested on cryopreserved sections of monkey cerebellum
(Medica, Carlsbad, CA) by IIF. Rabbit antibodies to peri-
centrin (a gift from Dr. D.A. Compton, Dartmouth Medi-
cal School, Hanover, NH) and human antibodies to the
Yo antigen [21] were used in co-localization experiments.
In some experiments, DNA was stained with DAPI to
allow for co-localization with centrosome staining. Slides
were viewed on a Leitz or a Zeiss Universal microscope fit-
ted with a TEC470 CCD video camera system (Optronics
Engineering, Goleta, CA) and images were processed with
a Sony Color Video Printer and recorded on Sony Type
1010 photography paper.
Immunoblotting recombinant centrosome proteins
Recombinant proteins were prepared from full-length
cDNAs representing five different centrosome autoanti-
gens using previously published protocols [11,22,23].
Briefly, cDNA inserts were amplified using standard
polymerase chain reaction protocols, and subcloned in
the Eco RI site of the expression vector pGEX-5X (Pharma-
cia Biotechnology, Uppsala, Sweden). Expression of
recombinant protein fused to a 28 kDa glutathione S
transferase (GST) leader sequence was induced with 0.1
mM IPTG. Bacteria were lysed by sonication, and insolu-
ble material was removed by centrifugation. GST fusion
proteins were purified directly from the bacterial lysates
using the affinity matrix glutathione Sepharose 4B. AfterBMC Pediatrics 2003, 3 http://www.biomedcentral.com/1471-2431/3/11
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binding and washing, the fusion proteins were eluted
under mild non-denaturing conditions using 10 mM
reduced glutathione in 50 mM Tris HC1 (pH 8.0).
Bacterial lysates that expressed the recombinant proteins
were resuspended in sodium dodecyl sulfate sample
buffer and denatured by boiling for 5 minutes as previ-
ously described [23]. The proteins were separated on a
10% SIDS-polyacrylamide gel, transferred to nitrocellu-
lose membranes (Bio-Rad, Hercules, CA), and incubated
with a 1:1000 dilution of the appropriate serum. The
recombinant proteins were produced from the SM-3 frag-
ment for human ninein, a clone representing base pairs
45–1778 of pericentrin, a cDNA representing PCM-1 and
designated 17A1 [24], two partial cDNAs (SM-1, SM-16)
for Cep250, and ninein. Secondary antibodies were poly-
valent horse radish peroxidase-conjugated goat anti-
human IgG, anti-mouse (IgG) or anti-rabbit IgG, IgA, and
IgM (Zymed, San Francisco, CA). Immunoreactive bands
were visualized using the ECL Western blotting system
(Amersham International, Princeton, NJ) [11].
Phospholipid ELISA
An anti-Phospholipid-8Pro-G EIA Kit (Alpco Diagnostics,
Windham, NH) was used to test for the presence of anti-
bodies against phospholipids: β2-glycoprotein I, β2-glyc-
oprotein I combined with cardiolipin in the same well
(β2-GP1 + CL), CL alone, phosphatidyl choline, phos-
phatidyl ethanolamine, phosphatidyl inositol, phosphati-
dyl serine, and sphingomyelin. Briefly, the serum samples
were diluted to 1:101 and then incubated with the specific
antigen in microtiter wells. The unbound antibodies were
washed away as per the manufacturer's instructions. An
anti-human immunoglobulin (IgG,A,M) secondary anti-
body conjugated to horseradish peroxidase was added
and incubated for 15 minutes at room temperature.
Unbound conjugate was washed off and the addition of
TMB-substrate generated an enzymatic colormetric reac-
tion, which was stopped by adding diluted acid. The reac-
tivities were read at an absorbance of 450 nm on a Biomek
1000 (Beckman) and cutoffs based on graded control pos-
itive and negative control sera provided with the kit.
Results and discussion
Eleven of 12 sera from children with post-varicella ataxia
had IgG antibodies that reacted with the centrosome of
formalin-fixed HeLa cells in an IIF assay (Figure 1). We
observed that commercially prepared substrates, such as
HEp-2 cells, were not sensitive for the detection of centro-
some autoantibodies but that the formalin-fixed HeLa
cells are a more reliable and sensitive substrate. When the
sera were tested for IgG antibodies by immunoblotting
(Figure 2), 10/12 reacted with at least one of the five cen-
trosome proteins: ninein, PCM 1, γγ-enolase, Mob-1, or
pericentrin (Table 1). Thus, one serum had autoantibod-
ies to a centrosome antigen that was not included in the
proteins listed above. Specifically, 5/12 (42%) reacted
with pericentrin (Figure 2), 3/12 (25%) with ninein, 6/12
(50%) with PCM 1, 3/12 (25%) with Mob-1, and 3/11
(27%) with γγ-enolase. By comparison, 3/5 siblings with
varicella infections but no ataxia, 1/1 with post-EBV
ataxia, 2/2 with ADEM, 1/2 with neuroblastoma and
Autoantibodies to centrosomes Figure 1
Autoantibodies to centrosomes Indirect immunofluorescence illustrating antibodies to centrosomes as seen in sera of 
children with post-varicella ataxia on formalin fixed HeLa cell substrate. The cells are counterstained with DAPI to identify the 
nucleus (a) and the pattern of staining and localization of centrosomes (arrows) is shown in panel b. Original magnification 
×400.BMC Pediatrics 2003, 3 http://www.biomedcentral.com/1471-2431/3/11
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ataxia, and 2/2 with cerebellitis had antibodies directed
against at least one of the centrosome proteins. None of
the 12 sera from other disease groups, including 20 chil-
dren with juvenile chronic arthritis, or 20 normal controls
reacted with pericentrin, although they did react with
other recombinant centrosome proteins. When convales-
cent sera were tested, the frequency of anti-centrosome
antibodies as detected by IIF and anti-pericentrin as
detected by immunoblotting decreased to 4/12 (33%) of
children with post-varicella ataxia, and none of the other
children sustained detectable reactivity at two weeks fol-
low-up. The number of sera from children with ataxia that
was not associated with varicella is admittedly small and
validation of our data would require multi-center studies
or access to large neurological or infectious diseases serum
banks.
The demographics, clinical profile and outcome of our
patients with post-varicella ataxia has been reported else-
where [9]. We are aware of only one report of virus or viral
antigen identification in varicella-associated cerebellar
ataxia [25]. A number of autoantibodies have been
reported in other post-infectious cerebellar syndromes.
Ito and his colleagues reported IgG and IgM anti-neuronal
antibodies that reacted with both nuclear and cytoplasmic
elements of Purkinje cells in acute cerebellar ataxia fol-
lowing infection [6]. In this study, the IgM reactivity grad-
ually decreased and the ataxia gradually improved. Sera
from 9 children with opsoclonus-myoclonus syndrome (3
associated with neuroblastoma and six with a prodromal
illness) had IgM and IgG binding to the cytoplasm of cer-
ebellar Purkinje cells and to some axons in white matter.
Western blot analysis showed a distinctive pattern of
binding to several neural proteins, including a 210 kDa
antigen identified as the high molecular weight subunit of
neurofilament [7]. Last, two children with central nervous
system manifestations (including ataxia) following Myco-
plasma pneumoniae infection were reported to develop
anti-centriole antibodies [8].
Table 1: Reactivity of sera from ataxia patients with centrosome proteins
Diagnosis (n) Pericentrin n (%) Ninein n (%) PCM 1/2 n (%) Mob1 n (%) γγ Enolase n (%)
Post-Varicella 5 (42) 3 (25) 6 (50) 3 (25) 3 (25)
Ataxia (12)
Varicella 0 (0) 2 (40) 0 (0) 1 (20) 2 (0)
No Ataxia (5)
Post-EBV 0 (0) 0 (0) 1 (100) 0 (0) 1 (100)
Ataxia (1)
ADEM (2) 0 (0) 1 (50) 1 (50) 1 (50) 1 (50)
Neuroblastoma 0 (0) 1 (50) 0 (0) 1 (50) 1 (50)
Ataxia (2)
Ataxia 0(0) 0 (0) 0 (0) 0 (0) 0 (0)
Telangiectasia (6)
Cerebellitis (2) 0 (0) 0 (0) 1 (50) 1 (50) 1 (50)
JCA (20) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Abbreviations: ADEM, acute disseminated encephalomyelitis; EBV, Epstein Barr virus; JCA, juvenile chronic arthritis.
Immunoblot of purified recombinant pericentrin Figure 2
Immunoblot of purified recombinant pericentrin 
Immunoblot of recombinant GST-pericentrin with sera from 
children with post-varicella ataxia (lanes c-j), an adult with 
idiopathic ataxia (lane k), and sera from a patient with sclero-
derma and anti-centrosome antibodies (lanes l). Controls 
included rabbit antibodies directed to recombinant pericen-
trin (lane a), murine antibodies to GST (lane b), and the 
index human anti-centrosome serum (lane m).BMC Pediatrics 2003, 3 http://www.biomedcentral.com/1471-2431/3/11
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Autoantibodies to centrosomes have also been associated
with systemic sclerosis and other conditions [10,11,26–
28]. These observations suggest that autoantibodies to
centrosomes as detected by IIF are not disease specific.
Studies of specific antibodies directed against pericentrin
showed that they are found in 27% of systemic sclerosis
sera [17]. Although ataxia or central nervous system
involvement is unusual in systemic sclerosis, these
patients, as well as patients with an autoimmune parane-
oplastic syndrome are known to have autonomic nervous
system dysfunction that is associated with antibodies
directed against antigens in the myenteric complex [29–
31].
Since unique reactivity with pericentrin was noted, we
proceeded to determine the distribution of pericentrin in
cerebellum tissue by IIF. We observed that pericentrin is
expressed in cerebellum as evidenced by intense staining
of centrosomes and less intense staining of neuronal
axons (Figures 3,4). Cells stained by human sera and rab-
bit antibodies to pericentrin were found throughout the
cerebellum including those in the nuclear and granular
layers. This observation is consistent with evidence that,
in addition to it being a component of centrosomes, peri-
centrin exists as particles in the cytoplasm [12]. We
observed that some cells, particularly certain Purkinje
cells, contain numerous particles and more than one cen-
trosome (Figure 3) and strong reactivity was also found in
adjacent cells that were consistent with the location and
appearance of Bergman glial cells (Figure 4). These obser-
vations are consistent with earlier observations that
Purkinje cells are polyploidy [32,33]. The observation that
children with ataxia produce antibodies to centrosome
proteins, including pericentrin, and that Purkinje cells are
polyploid raises the question of the vulnerability of these
cells to autoimmune attack. Although we have no direct
evidence to substantiate this hypothesis, in paraneoplastic
cerebellar degeneration where ataxia is a dominant clini-
cal feature, anti-Purkinje cell antibodies (APCA or anti-
Yo) are believed to be responsible for the Purkinje cell loss
that accompanies the disease [34,35]. This is supported by
observations that removal of the autoantibodies from the
circulation of a paraneoplastic cerebellar degeneration
patient provided improvement of cerebellar signs [36].
Of potential relevance to varicella-related ataxia, it was
observed that newly assembled viruses disrupt microtu-
bule organization, as well as centrosome duplication and
function [37,38]. This provides insight into mechanisms
by which varicella infection might lead to altered proteins
and neural function, and the subsequent production of
autoantibodies. Obviously, additional studies to deline-
ate differential expression of pericentrin and its interac-
tion with viral components in various cells and tissues are
required to substantiate this idea. Of interest, recent evi-
dence suggests that the centrosome may be an important
locus for MHC class I antigen processing and that target-
ing antigens to the centrosome enhances the immune
response [39].
A recent study [3] reported the presence of anti-phosphol-
ipid (APL) antibodies in children with acute varicella
Indirect immunofluorescence of cryopreserved monkey  cerebellum Figure 3
Indirect immunofluorescence of cryopreserved mon-
key cerebellum Sections of cryopreserved monkey cere-
bellum were reacted with human serum from a child with 
anti-centrosome antibodies and anti-pericentrin that was 
combined with low titer anti-Yo antibodies to visualize 
Purkinje cells. This shows that autoantibody reactivity is 
prominent in cells in the nuclear layer (left half of micro-
graph) and Purkinje cells (P, arrows) in the cerebellum and to 
a lesser extent in cells in the molecular layer (right half). 
Numerous discrete cytoplasmic speckles are seen in the 
Purkinje cells as illustrated in the enlarged cell (a, lower right 
inset). The nuclei of cells stained with DAPI (blue) is shown 
in panel b and this was overlayed on the IIF image from panel 
(a).BMC Pediatrics 2003, 3 http://www.biomedcentral.com/1471-2431/3/11
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infections. In this study we found 75% of the children
with post-varicella ataxia, 50% of children with varicella
but no ataxia, and none of the children with post-EBV
ataxia or cerebellitis had elevated APL as detected by
ELISA. All positive sera reacted with β2-GP1 + CL, three
reacted with CL alone, and individual sera reacted with
phosphatidyl inositol (post-varicella ataxia), phosphati-
dyl serine (varicella without ataxia) and sphingomyelin
(varicella without ataxia). These results confirmed that
children with varicella infections have a high frequency of
antibodies to phospholipids. In the previous study these
antibodies were found to be transiently associated with
infection and were not predictive of thrombotic complica-
tions [3]. In the clinical setting of assessing the risk of
thrombosis, a functional clotting assay may have more
clinical relevance. In our study the most common APL was
bound β2-GP1 + CL. However, these antibodies or other
the other PL antibodies showed no correlation with
ataxia. The specificity of APL for varicella infections was
indicated by the observation that patients with cerebellitis
and post-EBV ataxia did not have APL.
Conclusions
This is the first report to document that children with
post-varicella ataxia develop autoantibodies to a variety of
centrosome components. The reactivity of sera from chil-
dren with post-infectious varicella ataxia appears to be
unique in that they react with pericentrin. The origin of
centrosome autoantibodies as a sequelae of varicella
infection and the potential pathogenic role of antibodies
to pericentrin awaits further study.
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